Hubei Biocause Pharmaceutical Co., Ltd. - Wright Investors' Service

Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd. - Wright Investors' Service
Hubei Biocause Pharmaceutical Co., Ltd.
Published Mar 19, 2017
70 pages — Published Mar 19, 2017
Price US$ 75.00  |  Buy this Report Now

About This Report


A textual analysis of the financial results for Hubei Biocause Pharmaceutical Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Document ID
Primary ISIN
PDF Adobe Acrobat
Buy Now


TitleStarting PageNumber of Pages
Company Fundamentals111
  Company Profile12
  Comparative Business Analysis34
  Summary Analysis71
  Sales Analysis81
  Price Analysis92
  Earnings &Dividends Analysis111
Financial Statement Analyses1232
  Balance Sheet - Annual123
  Balance Sheet - Annual - Common Size153
  Balance Sheet - Annual - Year-Year % Change183
  Balance Sheet - Annual - Five-Year Averages213
  Balance Sheet - Interim243
  Balance Sheet - Interim - Common Size273
  Income Statement - Annual302
  Income Statement - Annual - Common Size322
  Income Statement - Year-Year % Change342
  Income Statement - Five-Year Averages362
  Income Statement - Interim382
  Income Statement - Interim - Common Size402
  Sources of Capital - Net Change422
Financial Ratio Analyses449
  Accounting Ratios441
  Asset Utilization451
  Employee Efficiency461
  Fixed Charges Coverage471
  Leverage Analysis482
  Liquidity Analysis501
  Per-Share Ratios511
  Profitability Growth521
Wright Quality Rating Analyses534
  Investment Acceptance531
  Financial Strength541
  Profitability &Stability551
  Corporate Growth561
Industry Overview571
  Wright Industry Averages - Overview571
Industry Financial Statement Analyses589
  Summary Analysis582
  Sales Analysis601
  Income Statement 612
  Balance Sheet632
  Sources of Capital 652
Industry Financial Ratio Analyses673
  Leverage Analysis671
  Per-Share Data681
  Profitability Analysis691
Wright Quality Rating Overview701
  Explanation of Wright Quality Rating701

Table Of Contents

Wright Investors' Service—Company reports include: analyses of financial statements, extensive ratio tables, proprietary Wright Quality Rating® analyses reports and a textual review of the financial results of the company and three of its peers. Also included are: recent stock performance, profitability analysis, dividend analysis, and key data items. Additional research includes sub-reports for: sales, earnings, and security prices. Financial results of the company can be compared to industry performance by viewing a series of industry-specific averages reports that are also included.

About the Author

Cite this Report

Wright Investors' Service. "Hubei Biocause Pharmaceutical Co., Ltd." Mar 19, 2017. Alacra Store. Apr 30, 2017. <>
Wright Investors' Service. (2017). Hubei Biocause Pharmaceutical Co., Ltd. Mar 19, 2017. New York, NY: Alacra Store. Retrieved Apr 30, 2017 from <>
US$ 75.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Company Profiles from one place.